Strategic Partnerships Jana Care has a history of collaboration with major players like Roche Diagnostics and Siemens Healthineers, indicating a strong openness to co-development and distribution partnerships that can be leveraged to accelerate market access for new biomarker assays and the Aina platform.

Financing Momentum Recent financing rounds and board additions signal investor confidence and potential for capital to scale commercialization efforts, enabling expansion of sales teams, regulatory activities, and larger pilot programs with healthcare providers.

Chronic Disease Focus The portfolio targets chronic kidney disease and heart failure with self-administered blood tests and smartphone-based analytics, presenting up-sell opportunities to hospitals, clinics, and direct-to-consumer programs centered on chronic disease management.

Global Reach Operations spanning Boston and Bangalore with a global development footprint suggest readiness to scale through regional partnerships, local manufacturing or distribution agreements, and multinational health systems adoption.

Digital Health Platform Aina’s smartphone-enabled diagnostics combined with predictive analytics creates cross-sell potential with digital health vendors, telemedicine platforms, and payer programs seeking remote-monitoring capabilities and actionable patient insights.